Anna Marrs Sells 365 Shares of Docusign (NASDAQ:DOCU) Stock

Docusign Inc. (NASDAQ:DOCU) Director Anna Marrs sold 365 shares of the stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $55.04, for a total transaction of $20,089.60. Following the completion of the sale, the director owned 12,615 shares in the company, valued at $694,329.60. The trade was a 2.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Anna Marrs also recently made the following trade(s):

• On Thursday, March 5th, Anna Marrs sold 363 shares of Docusign stock. The stock was sold at an average price of $46.33, for a total transaction of $16,817.79.

Docusign Price Performance

NASDAQ:DOCU opened at $52.40 on Thursday. The firm has a market capitalization of $10.18 billion, a P/E ratio of 35.41, a PEG ratio of 2.10 and a beta of 0.92. Docusign Inc. has a 1-year low of $40.16 and a 1-year high of $94.67. The company’s fifty day moving average price is $47.64 and its 200-day moving average price is $54.33.

Docusign (NASDAQ:DOCU) last released its quarterly earnings data on Tuesday, March 17th. The company reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.95 by $0.06. The firm had revenue of $836.86 million for the quarter, compared to analyst estimates of $828.23 million. Docusign had a net margin of 9.60% and a return on equity of 16.86%. The business’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.86 earnings per share. Equities analysts anticipate that Docusign Inc. will post 1.76 EPS for the current fiscal year.

Docusign announced that its board has approved a stock buyback plan on Tuesday, March 17th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the company to buy up to 21% of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s board believes its shares are undervalued.

Docusign News Roundup

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Docusign announced its app is now available in ChatGPT and Codex, extending its Intelligent Agreement Management platform into OpenAI products and potentially improving adoption by making agreement workflows easier to use. Docusign Brings Trusted Agreement Intelligence and Workflows into ChatGPT and Codex
• Positive Sentiment: The company appointed Graham Sheldon as Chief Product Officer, a move aimed at accelerating its AI-focused product strategy and strengthening product execution. Docusign Appoints Graham Sheldon as Chief Product Officer to Accelerate Intelligent Agreement Management Vision
• Neutral Sentiment: Investor focus is centered on Thursday’s earnings release, where the key question is whether recent AI initiatives are driving enough momentum to support the stock. DocuSign (DOCU) Q1 Earnings Report Preview: What To Look For
• Neutral Sentiment: Multiple directors sold small amounts of stock, including Anna Marrs, James A. Beer, and Teresa Briggs, but the trades were modest and were executed under Rule 10b5-1 plans, which typically limits their significance. SEC filing: Anna Marrs Form 4
• Neutral Sentiment: Recent commentary also highlighted Docusign as an earnings-watch name, reinforcing that the stock may move on management’s outlook and proof of execution rather than the insider activity. Dear Docusign Stock Fans, Mark Your Calendars for June 4

Analysts Set New Price Targets

Several research firms recently commented on DOCU. Wells Fargo & Company dropped their price target on shares of Docusign from $75.00 to $60.00 and set an “equal weight” rating on the stock in a research report on Wednesday, March 18th. Jefferies Financial Group lowered shares of Docusign from a “buy” rating to a “hold” rating and dropped their price target for the company from $105.00 to $45.00 in a research report on Monday, February 23rd. Citigroup lowered shares of Docusign from a “buy” rating to a “neutral” rating and dropped their price target for the company from $99.00 to $50.00 in a research report on Friday, April 10th. HSBC set a $53.00 price target on shares of Docusign in a research report on Friday, February 13th. Finally, Citizens Jmp dropped their price target on shares of Docusign from $124.00 to $86.00 and set a “market outperform” rating on the stock in a research report on Wednesday, March 18th. Three investment analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, Docusign currently has a consensus rating of “Hold” and an average price target of $61.40.

Hedge Funds Weigh In On Docusign

Several hedge funds and other institutional investors have recently added to or reduced their stakes in DOCU. Norges Bank purchased a new position in Docusign during the fourth quarter valued at $186,795,000. Arrowstreet Capital Limited Partnership lifted its holdings in Docusign by 76.1% during the first quarter. Arrowstreet Capital Limited Partnership now owns 5,285,128 shares of the company’s stock valued at $250,568,000 after purchasing an additional 2,283,996 shares in the last quarter. Capital World Investors lifted its holdings in Docusign by 38.1% during the fourth quarter. Capital World Investors now owns 5,815,804 shares of the company’s stock valued at $397,801,000 after purchasing an additional 1,603,900 shares in the last quarter. SG Americas Securities LLC lifted its holdings in Docusign by 452.3% during the first quarter. SG Americas Securities LLC now owns 1,314,632 shares of the company’s stock valued at $62,327,000 after purchasing an additional 1,076,622 shares in the last quarter. Finally, Woodline Partners LP lifted its holdings in Docusign by 24,412.7% during the third quarter. Woodline Partners LP now owns 958,938 shares of the company’s stock valued at $69,130,000 after purchasing an additional 955,026 shares in the last quarter. 77.64% of the stock is owned by hedge funds and other institutional investors.

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.